Trial Profile
A prospective, observational study to evaluate the basiliximab induction for new onset diabetes after transplantation for living donor renal allograft recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Basiliximab (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 19 Dec 2015 New trial record